Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX)

CUSIP: 90042W100

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
23,142,592
Total 13F shares
8,434,667
Share change
-1,958,428
Total reported value
$3,026,098
Price per share
$0.36
Number of holders
23
Value change
-$754,416
Number of buys
7
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 90042W100?
CUSIP 90042W100 identifies TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) as of Q2 2025

As of 30 Jun 2025, Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,434,667 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, BML Capital Management, LLC, TAKEDA PHARMACEUTICAL CO LTD, Point72 Asset Management, L.P., 72 Investment Holdings, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, DELTEC ASSET MANAGEMENT LLC, and VANGUARD GROUP INC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.